Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

The role of genetic variants of Stromal cell-Derived Factor 1 in pediatric HIV-1 infection and disease progression.

Gianesin K, Freguja R, Carmona F, Zanchetta M, Del Bianco P, Malacrida S, Montagna M, Rampon O, Giaquinto C, De Rossi A.

PLoS One. 2012;7(9):e44460. doi: 10.1371/journal.pone.0044460. Epub 2012 Sep 4.

2.

Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.

Mild M, Kvist A, Esbjörnsson J, Karlsson I, Fenyö EM, Medstrand P.

Infect Genet Evol. 2010 Apr;10(3):356-64. doi: 10.1016/j.meegid.2009.05.003. Epub 2009 May 14.

PMID:
19446658
3.

HIV-1 with multiple CCR5/CXCR4 chimeric receptor use is predictive of immunological failure in infected children.

Cavarelli M, Karlsson I, Zanchetta M, Antonsson L, Plebani A, Giaquinto C, Fenyö EM, De Rossi A, Scarlatti G.

PLoS One. 2008 Sep 29;3(9):e3292. doi: 10.1371/journal.pone.0003292.

4.

Higher prevalence of predicted X4-tropic strains in perinatally infected older children with HIV-1 subtype C in India.

Neogi U, Sahoo PN, Arumugam K, Sonnerborg A, De Costa A, Shet A.

J Acquir Immune Defic Syndr. 2012 Apr 1;59(4):347-53. doi: 10.1097/QAI.0b013e3182405c7b.

PMID:
22107818
5.
6.

Protective effect of CCR5 delta 32 heterozygosity is restricted by SDF-1 genotype in children with HIV-1 infection.

Sei S, Boler AM, Nguyen GT, Stewart SK, Yang QE, Edgerly M, Wood LV, Brouwers P, Venzon DJ.

AIDS. 2001 Jul 27;15(11):1343-52.

PMID:
11504955
7.

Haplotype analysis of the SDF-1 (CXCL12) gene in a longitudinal HIV-1/AIDS cohort study.

Modi WS, Scott K, Goedert JJ, Vlahov D, Buchbinder S, Detels R, Donfield S, O'brien SJ, Winkler C.

Genes Immun. 2005 Dec;6(8):691-8.

PMID:
16177829
8.

Link between the X4 phenotype in human immunodeficiency virus type 1-infected mothers and their children, despite the early presence of R5 in the child.

Casper CH, Clevestig P, Carlenor E, Leitner T, Anzén B, Lidman K, Belfrage E, Albert J, Bohlin AB, Navér L, Lindgren S, Fenyö EM, Ehrnst AC.

J Infect Dis. 2002 Oct 1;186(7):914-21. Epub 2002 Sep 9.

9.

Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progression.

Borggren M, Repits J, Kuylenstierna C, Sterjovski J, Churchill MJ, Purcell DF, Karlsson A, Albert J, Gorry PR, Jansson M.

Retrovirology. 2008 Mar 27;5:28. doi: 10.1186/1742-4690-5-28.

10.

CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HIV Infection Study Group.

Misrahi M, Teglas JP, N'Go N, Burgard M, Mayaux MJ, Rouzioux C, Delfraissy JF, Blanche S.

JAMA. 1998 Jan 28;279(4):277-80.

PMID:
9450710
11.

Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection.

Singh KK, Barroga CF, Hughes MD, Chen J, Raskino C, McKinney RE, Spector SA.

J Infect Dis. 2003 Nov 15;188(10):1461-72. Epub 2003 Nov 18.

12.

HIV type 1 chemokine receptor usage in mother-to-child transmission.

Salvatori F, Scarlatti G.

AIDS Res Hum Retroviruses. 2001 Jul 1;17(10):925-35.

PMID:
11461678
13.

HIV-1 coreceptor usage, transmission, and disease progression.

Philpott SM.

Curr HIV Res. 2003 Apr;1(2):217-27. Review.

PMID:
15043204
14.

The evolution of human immunodeficiency virus type-1 (HIV-1) envelope molecular properties and coreceptor use at all stages of infection in an HIV-1 donor-recipient pair.

Edo-Matas D, Rachinger A, Setiawan LC, Boeser-Nunnink BD, van 't Wout AB, Lemey P, Schuitemaker H.

Virology. 2012 Jan 5;422(1):70-80. doi: 10.1016/j.virol.2011.10.005. Epub 2011 Nov 1.

15.

HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.

Wilkin TJ, Su Z, Kuritzkes DR, Hughes M, Flexner C, Gross R, Coakley E, Greaves W, Godfrey C, Skolnik PR, Timpone J, Rodriguez B, Gulick RM.

Clin Infect Dis. 2007 Feb 15;44(4):591-5. Epub 2007 Jan 17. Erratum in: Clin Infect Dis. 2007 May 15;44(10):1399.

16.

Stromal cell-derived factor-1 genotype, coreceptor tropism, and HIV type 1 disease progression.

Daar ES, Lynn HS, Donfield SM, Lail A, O'Brien SJ, Huang W, Winkler CA; Hemophilia Growth and Development Study.

J Infect Dis. 2005 Nov 1;192(9):1597-605. Epub 2005 Sep 30.

17.

High prevalence of X4/DM-tropic variants in children and adolescents infected with HIV-1 by vertical transmission.

Briz V, García D, Méndez-Lagares G, Ruiz-Mateos E, de Mulder M, Moreno-Pérez D, Navarro ML, León-Leal JA, de José MI, Ramos JT, Mellado MJ, González-Tomé MI, Leal M, Muñoz-Fernández MA.

Pediatr Infect Dis J. 2012 Oct;31(10):1048-52.

PMID:
22828644
18.

Correlation of coreceptor usage and disease progression.

Verhofstede C, Nijhuis M, Vandekerckhove L.

Curr Opin HIV AIDS. 2012 Sep;7(5):432-9. doi: 10.1097/COH.0b013e328356f6f2. Review.

PMID:
22871636
19.

Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences.

Jensen MA, Li FS, van 't Wout AB, Nickle DC, Shriner D, He HX, McLaughlin S, Shankarappa R, Margolick JB, Mullins JI.

J Virol. 2003 Dec;77(24):13376-88.

20.

Relevance of early detection of HIV type 1 SI/CXCR4-using viruses in vertically infected children.

Crudeli CM, Aulicino PC, Rocco CA, Bologna R, Mangano A, Sen L.

AIDS Res Hum Retroviruses. 2012 Jul;28(7):685-92. doi: 10.1089/AID.2011.0111. Epub 2011 Dec 2.

Items per page

Supplemental Content

Write to the Help Desk